Joana Goncalves insider trades: Oruka Therapeutics (ORKA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joana reports to the SEC
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | ORKA | ↓ Sell | 7,000 | $74.81 | $524K | Direct | Oct 15, 2026 (0d) |
| Sep 15, 2026 | ORKA | ↓ Sell | 7,947 | $92.38 | $734K | Direct | Sep 15, 2026 (0d) |
| Aug 17, 2026 | ORKA | ↓ Sell | 7,000 | $111.84 | $783K | Direct | Aug 17, 2026 (0d) |
| Jul 15, 2026 | ORKA | ↓ Sell | 7,000 | $86.28 | $604K | Direct | Jul 15, 2026 (0d) |
| Jun 15, 2026 | ORKA | ↓ Sell | 7,947 | $69.28 | $551K | Direct | Jun 15, 2026 (0d) |
| May 15, 2026 | ORKA | ↓ Sell | 7,000 | $61.85 | $433K | Direct | May 15, 2026 (0d) |
| Apr 15, 2026 | ORKA | ↓ Sell | 7,000 | $66.12 | $463K | Direct | Apr 15, 2026 (0d) |
| Mar 16, 2026 | ORKA | ↓ Sell | 7,641 | $40.91 | $313K | Direct | Mar 17, 2026 (1d) |
| Feb 17, 2026 | ORKA | ↓ Sell | 7,000 | $32.37 | $227K | Direct | Feb 17, 2026 (0d) |
| Jan 15, 2026 | ORKA | ↓ Sell | 7,000 | $31.81 | $223K | Direct | Jan 16, 2026 (1d) |
| Dec 19, 2025 | ORKA | ↓ Sell | 7,000 | $30.61 | $214K | Direct | Dec 19, 2025 (0d) |
| Apr 5, 2024 | CARA | ↓ Sell | 2,753 | $0.83 | $2K | Direct | Apr 9, 2024 (4d) |
| Feb 29, 2024 | CARA | ↓ Sell | 3,293 | $0.89 | $3K | Direct | Mar 4, 2024 (4d) |
| Jun 23, 2023 | CARA | ↓ Sell | 2,723 | $3.51 | $10K | Direct | Jun 27, 2023 (4d) |
| Apr 4, 2023 | CARA | ↓ Sell | 2,481 | $4.91 | $12K | Direct | Apr 6, 2023 (2d) |
| Mar 3, 2023 | CARA | ↓ Sell | 6,221 | $9.71 | $60K | Direct | Mar 7, 2023 (4d) |
| Feb 16, 2023 | CARA | ↓ Sell | 2,265 | $10.20 | $23K | Direct | Feb 17, 2023 (1d) |
| Feb 8, 2023 | CARA | ↓ Sell | 7,770 | $0.53 | $4K | Direct | Feb 12, 2024 (369d) |
| Jan 17, 2023 | CARA | ↓ Sell | 2,265 | $10.81 | $24K | Direct | Jan 19, 2023 (2d) |
| Dec 29, 2022 | CARA | ↓ Sell | 2,265 | $10.18 | $23K | Direct | Jan 3, 2023 (5d) |
| Dec 21, 2022 | CARA | ↓ Sell | 2,992 | $11.27 | $34K | Direct | Dec 23, 2022 (2d) |
| Apr 1, 2022 | CARA | ↓ Sell | 1,642 | $11.91 | $20K | Direct | Apr 5, 2022 (4d) |
| Feb 25, 2022 | CARA | ↓ Sell | 1,972 | $10.29 | $20K | Direct | Mar 1, 2022 (4d) |
| Nov 1, 2021 | CARA | ↓ Sell | 1,000 | $17.15 | $17K | Direct | Nov 3, 2021 (2d) |
| Oct 27, 2021 | CARA | ↓ Sell | 1,000 | $15.00 | $15K | Direct | Oct 28, 2021 (1d) |
| Aug 30, 2021 | CARA | ↓ Sell | 2,110 | $14.20 | $30K | Direct | Sep 1, 2021 (2d) |
| Apr 21, 2021 | CARA | ↓ Sell | 3,000 | $27.63 | $83K | Direct | Apr 23, 2021 (2d) |
| Mar 22, 2021 | CARA | ↓ Sell | 3,000 | $19.65 | $59K | Direct | Mar 24, 2021 (2d) |
| Mar 5, 2021 | CARA | ↓ Sell | 3,093 | $17.98 | $56K | Direct | Mar 8, 2021 (3d) |
| Feb 25, 2021 | CARA | ↓ Sell | 3,372 | $19.33 | $65K | Direct | Feb 25, 2021 (0d) |
| Feb 22, 2021 | CARA | ↓ Sell | 2,000 | $19.73 | $39K | Direct | Feb 24, 2021 (2d) |
| Jan 21, 2021 | CARA | ↓ Sell | 2,000 | $20.12 | $40K | Direct | Jan 25, 2021 (4d) |
| Dec 30, 2020 | CARA | ↓ Sell | 1,298 | $15.30 | $20K | Direct | Dec 30, 2020 (0d) |
| Dec 21, 2020 | CARA | ↓ Sell | 2,000 | $15.00 | $30K | Direct | Dec 23, 2020 (2d) |
| Nov 23, 2020 | CARA | ↓ Sell | 2,000 | $15.31 | $31K | Direct | Nov 25, 2020 (2d) |
| Nov 10, 2020 | CARA | ↓ Sell | 2,000 | $15.00 | $30K | Direct | Nov 13, 2020 (3d) |
| Oct 20, 2020 | CARA | ↓ Sell | 2,000 | $15.00 | $30K | Direct | Oct 22, 2020 (2d) |
| Jun 12, 2020 | CARA | ↓ Sell | 10,627 | $15.20 | $162K | Direct | Jun 12, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORKA insiders
Open-market trades in the last 12 months
About Joana Goncalves's insider trades
Joana Goncalves is Chief Medical Officer at Oruka Therapeutics (ORKA). Since Jun 12, 2020, Joana has reported no open-market purchases and 38 sales worth $6.0M on SEC Form 4. In the last 12 months: 11 sales ($5.1M).
Their filings also include grants and awards (14 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORKA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.